Breaking Vaccines News

Find the latest Vaccines News from News Break the most trusted news destination from around the web.

Flu ‎vaccine‏s reserved for sickest amid unprecedented shortage

Following 2017's horror flu season more than 1.5 million people have been vaccinated in Victoria, and supplies are now exhausted, the health department says.

BALLARAT COURIER - 2018-05-25 00:14:00

HPV ‎vaccine‏ also has a downside

China has approved a new HPV (human papillomavirus) vaccine that combats nine strains of the virus, the leading cause of cervical cancer, which after breast cancer is the second most common cancer in women aged 15 to 44 in China.

CHINA DAILY - 2018-05-25 00:00:00

Searching For A Universal ‎Vaccine‏ For Influenza

Researchers at the University of Nebraska-Lincoln are looking for a universal vaccine for the influenza virus. They are attempting to combine ancestral genes from other major strains of influenza with the hope of protecting the young and old alike. In the United States, 30,000 people die annually fr


Victoria rations flu ‎vaccine‏ to vulnerable

Victoria will ration its flu vaccine to children, elderly and sick people until the Commonwealth can deliver a stable supply for all people eager to get the jab, the state government says.


How ‎Vaccine‏ Fears Helped Kill the Lyme Disease ‎Vaccine‏

Getty ImagesLyme disease is the fastest-growing vector-borne (bug-transmitted) infection in the United States today, according to the Centers for Disease Control and Prevention (CDC), and stopping the spread of the disease is difficult.In fact, in 2016, the confirmed number of cases of Lyme disease


HIV ‎Vaccine‏ Day

“If they do not give us a vaccine they will at least give us information about how it works,” said Dr. Francis Kiweewa, the head of research and scientific affairs at Makerere University Walter Reeds Project (MUWRP).


Eurocine ‎Vaccine‏s has Completed Dosing of its Quadrivalent Influenza ‎Vaccine‏ Candidate , Immunose ™ FLU , in the Second Clinical Study

STOCKHOLM,May 18. 2018 /PRNewswire/ -- This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and effective nasal influenza vaccine. " class="canvas-atom canvas-text Mb(1.0em) Mb(0)--sm Mt(0.8em)--sm">STOCKHOLM,May


WHO sends first doses of experimental ‎vaccine‏ to tackle Congo Ebola outbreak

The World Health Organization sent the first 4,000 doses of an Ebola vaccine to Congo on Wednesday, the first time the experimental vaccine has been deployed since it was developed during the last big outbreak two years ago.


Ashland moves forward on mandatory Hep A ‎vaccine‏

“An ordinance of the city of Ashland, Kentucky, adopting regulations for the businesses/entities providing food services within the city of Ashland, Kentucky, requiring Hepatitis A inoculations for workers engaged in the handling of food to be consumed by the public.”

DAILY INDEPENDENT - 2018-05-25 10:00:00

A Live-Attenuated Herpes Simplex Virus ‎Vaccine‏ Candidate

“VC2” is an infectious, attenuated vaccine candidate made by removing 37 amino acids from viral glycoprotein K and 19 amino acids of the UL20 protein. The deletion in glycoprotein K prevents the virus from entering the axonal termini of ganglionic neurons and establishing latency. The UL20 protein a

VIROLOGY.WS - 2018-05-24 00:00:00

Manage Your Childern ‎Vaccine‏ Chart @spanmylife

Manage Your Childern Vaccine chartShow Full TextMore info:Manage Your Childern Vaccine Chart @spanmylifeManage Your Childern Vaccine chartShow Full TextMore info:Anyone can write on Bored Panda.Start writing!


NIH statement on HIV ‎Vaccine‏ Awareness Day

Daily antiretroviral treatment keeps those living with HIV healthy, and also prevents sexual transmission of the virus when it is durably suppressed in the HIV-positive partner. Pre-exposure prophylaxis, or PrEP, is highly effective at preventing HIV acquisition when HIV-negative people who want to


CEPI Partners with the International AIDS ‎Vaccine‏ Initiative to Advance Lassa Fever ‎Vaccine‏ Development

The partnership will support the development of IAVI’s replicating viral vector-based Lassa vaccine candidate, rVSVΔG-LASV-GPC. CEPI will provide US$10.4 million to support the first phase of the project, with options to invest up to a total of US$54.9 million over five years (including stockpile).


World marks HIV ‎Vaccine‏ Awareness Day

Much as this may seem too long, there are vaccines that are in use today, but they took decades to develop.


Healthcast : ‎Vaccine‏ for Zika Virus

ST. LOUIS, Mo. (Ivanhoe Newswire) - What’s the deadliest creature on earth? Do sharks, crocodiles or snakes come to mind? Well, deaths from those creatures pale in comparison to mosquitos. Globally, mosquitos kill more than 700,000 people a year. Researchers are now testing a vaccine that will prote


Flu ‎vaccine‏ shortage no cause for alarm : Murrumbidgee Health

REST EAST: Director of public health for the Murrumbidgee Local Health Area, Tracey Oakman, says the flu vaccine shortage is no cause for alarm.

BORDER MAIL - 2018-05-24 00:52:00

GeoVax Awarded NIH Grant for Novel Zika ‎Vaccine‏

ATLANTA, GA, , May 24, 2018 (GLOBE NEWSWIRE) --GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company aSmall B

CONSUMER ELECTRONICS NET - 2018-05-24 00:00:00

Why the world needs more than one Ebola ‎vaccine‏

LONDON: - In the life-and-death race to make the first effective vaccine against Ebola, one company: Merck: seems bound to win.But others drugmakers, such as Johnson & Johnson and GlaxoSmithKline, are also in the running - and must stick with it even though they are unlikely to make a profit, expert

CHANNEL NEWSASIA - 2018-05-23 14:55:22

Biotech Announces Encouraging HIV ‎Vaccine‏ Results

May 23, 2018 (Investorideas.com Newswire) Ram Selvaraju, an analyst with H.C. Wainwright & Co., explained the recently released data from a study of one of this immunotherapy firm's therapeutics.


Merck 's Ebola ‎vaccine‏ arrives in Congo

A first batch of Merck & Co.’s experimental Ebola vaccine, V920, has arrived in Kinshasa, Democratic Republic of the Congo, according to the World Health Organization. The 4,000 doses of vaccine are meant to stem the spread of the deadly virus following a fresh outbreak in the region. As of May 14,